A Role of HMGIC in Squamous Carcinoma Cells of The Oral Cavity
A Role of HMGIC in Squamous Carcinoma Cells of The Oral Cavity
批准号:
16591898
负责人:
IMAI Kazushi
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
在先前的研究中,我们发现转录因子高迁移率族蛋白(HMGIC/HMGA2)在口腔癌中的表达频繁,并与患者的5年生存率有关。了解HMGIC表达的作用应该扩大对癌症进展的分子机制(S)的知识。为此,我们开发了一种新的高通量分析方法,称为SChIP,用于揭示HMGA2靶基因。我们确定了大约。100个基因,集中在5个不同的基因上,这些基因有望参与口腔癌的进展。RT-PCR结果显示,这5个基因在分化的HaCaT角质形成细胞中几乎不表达,而在未分化的HaCaT细胞中表达上调。此外,未表达HMGIC基因的口腔癌细胞(KOSC3、Ho1u1)不表达这5个基因,而表达HMGIC基因的口腔癌细胞(HOC313、TSU)则不表达这5个基因。为了了解HMGIC的转录活性,我们目前正在通过荧光素酶系统的报告分析来研究它。HMGIC靶基因在从缺氢小鼠分离的角质形成细胞中的表达也在调查中。我们将建立通过RNAi特异性击倒HMGA2基因的癌细胞株,并分析HMGIC和靶基因对肿瘤的致瘤性、侵袭性、转移潜能和表型变化的直接作用。
英文摘要
In a previous study, we showed that expression of a transcription factor-high mobility group protein (HMGIC/HMGA2), which plays a critical role in differentiation and growth of un-differentiated mesenchymal cells during development, is frequently observed in oral carcinomas and associates with 5-year survival rate of patients suffered from the disease. Understanding a role of HMGIC expression should expand knowledge of a molecular mechanism(s) of cancer progression. In this end, we developed a novel high-throughput analysis, named sChIP, to unveil HMGA2 target genes. We identified approx. 100 genes, and focused on 5 different genes, which are expected to be involved in the progression of oral carcinomas. RT-PCR showed that expression of these 5 genes were negligible in differentiated HaCaT keratinocytes but upregulated in undifferentiated HaCaT cells. In addition, oral carcinoma cells without HMGIC expression (KOSC3, Ho1u1) did not express these 5 genes in contrast to the expression in carcinoma cells expressing HMGIC gene (HOC313, TSU). To understand the transcriptional activity of HMGIC, we are currently investigating it by a reporter assay using luciferase system. Expression of HMGIC target genes in keratinocytes isolated from Hmgic-null mice is also under investigation. We will develop carcinoma cell lines which are specifically knock-downed HMGA2 gene by RNAi, and analyze a direct role of HMGIC and the target genes on tumorgenisity, and invasiveness, metastatic potential and phenotypic alterations of carcinoma cells.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3892/ijo.27.6.1535
发表时间:
2005-12
期刊:
International journal of oncology
影响因子:
5.2
作者:
[G. Maeda;T. Chiba;M. Okazaki;T. Satoh;Y. Taya;T. Aoba;K. Kato;S. Kawashiri;K. Imai]
通讯作者:
G. Maeda;T. Chiba;M. Okazaki;T. Satoh;Y. Taya;T. Aoba;K. Kato;S. Kawashiri;K. Imai
Ectopic activation of mesenchyme-specific genes induce the epithelial mesenchymal transition in oral cancer.
间充质特异性基因的异位激活诱导口腔癌的上皮间质转化。
DOI:
--
发表时间:
2005
期刊:
Res.Adv.in Cancer 5
影响因子:
--
作者:
[M.Nasu, F.Mitsuhashi, T.Yosue et al., Kazushi Imai]
通讯作者:
Kazushi Imai
Ectopic activation of mesenchyme-specific genes induce the epithelial-mesenchymal transition in oral cancer, in "Research Advances in Cancer"
间充质特异性基因的异位激活诱导口腔癌的上皮间充质转化,在“癌症研究进展”中
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Aida Y, Maeno M, Suzuki N, Shiratsuchi H, Motohashi M, Matsumura H., Kazushi Imai]
通讯作者:
Kazushi Imai
転写因子の標的遺伝子検出方法
一种转录因子靶基因的检测方法
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ectopic activation of mesenchyme-specific genes induce the epithelial-mesenchymal transition in oral cancer.
间充质特异性基因的异位激活诱导口腔癌的上皮-间质转化。
DOI:
--
发表时间:
2005
期刊:
Res. Adv. in Cancer 5
影响因子:
--
作者:
[Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M, Koichiro Ueda, Kazushi Imai]
通讯作者:
Kazushi Imai
共 7 条
Inhibition of NFκB activity by MALT1 and its involvement in phenotypic alterations of oral carcinoma cells
-
批准号:22592103
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:IMAI Kazushi
-
依托单位:
Astudy on the mechanism of oral carcinoma progression upon the suppression of NF kB transcriptional activity by the nucleus-localization MALT1.
-
批准号:18592073
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2006
-
负责人:IMAI Kazushi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CircSKA3通过抑制HMGA2泛素化降解调控巨噬细胞M2型分化促进卵巢癌转移的机制研究
-
批准号:QN25H160107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邓静雯
-
依托单位:
Fra-1通过转录激活胃癌细胞HMGA2表达调控巨噬细胞极化的机制研究
-
批准号:2025JJ80863
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:许娟
-
依托单位:
HMGA2介导TMAO抑制结直肠癌细胞铁死亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:蒋海忠
-
依托单位:
XPA结合蛋白2通过HMGA2可变剪接影响卵巢癌铂耐药的机制研究
-
批准号:2025JJ70423
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:田焱
-
依托单位:
SMC1A/HNRNPA2B1/HMGA2 轴调控人精原干细胞
自我更新和凋亡的作用及机制研究
-
批准号:2024JJ5517
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳威
-
依托单位:
HMGA2调节DNA甲基化水平介导BCL-2上调促进肺癌对奥希替尼耐
药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:戴富强
-
依托单位:
HMGA2/AKT/CCN2信号通路调控SASP在衰老肌腱干细胞分化失
平衡中的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:代广春
-
依托单位:
SRSF1调控MEG3可变剪切对HMGA2重编程促进生长激素型垂体腺瘤发生的机制研究
-
批准号:82303127
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:朱文德
-
依托单位:
外泌体circMYCBP2调控NAT10重塑HMGA2的ac4C修饰促进胶质母细胞瘤耐药的作用机制研究
-
批准号:82303104
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:耿秀超
-
依托单位:
大黄素通过HMGA2/Caspase-3/GSDME通路介导慢性肾脏病肾小管上皮细胞焦亡的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位: